MedPath

Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.

Phase 3
Terminated
Conditions
Osteoarthritis
Interventions
Registration Number
NCT00320801
Lead Sponsor
Purdue Pharma LP
Brief Summary

The original objective of this study was to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (BTDS) 20 micrograms (mcg)/hour (h) in comparison to the buprenorphine transdermal system 5 mcg/h in subjects with moderate to severe osteoarthritis pain currently treated with oral opioids. The double-blind treatment intervention duration is 12 weeks during which time supplemental analgesic medication (acetaminophen or ibuprofen) will be provided to all subjects in addition to study drug.

This study was terminated early due to administrative reasons with only 20% of the planned sample size; therefore, the primary objective was changed to focus on the safety evaluation.

Detailed Description

Buprenorphine is a synthetic opioid analgesic with over 25 years of international clinical experience indicating it to be safe and effective in a variety of therapeutic situations for the relief of moderate to severe pain.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
188
Inclusion Criteria
  • osteoarthritis of the hip, knee, or spine for 1 year or longer.
  • taking between 30-80 milligrams (mg) of oral morphine sulfate or equivalent/day, at least 4 days a week.
Exclusion Criteria
  • taking more than 80 mg per day of oral morphine sulfate or equivalent within 30 days of enrollment.
  • requiring frequent analgesic therapy for chronic conditions in addition to osteoarthritis.

Other protocol-specific exclusion/inclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BTDS 5Buprenorphine transdermal patchBuprenorphine transdermal patch 5 mcg/h, applied for 7-day wear
BTDS 20Buprenorphine transdermal patchBuprenorphine transdermal patch 20 mcg/h, applied for 7-day wear
Primary Outcome Measures
NameTimeMethod
The Number of Participants With Adverse Events (AEs) as a Measure of Safety.Throughout BTDS exposure (Includes run-in period, double-blind phase and extension phase)

Safety assessments included monitoring and recording of all adverse events and serious adverse events (SAEs).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (61)

Comprehensive Clinical Research

🇺🇸

Berlin, New Jersey, United States

Southern Oregon Health & Wellness

🇺🇸

Medford, Oregon, United States

Sidney Hillman Medical Center

🇺🇸

Philadelphia, Pennsylvania, United States

NuLife Clinical Research, Inc.

🇺🇸

Anaheim, California, United States

Private Practice

🇺🇸

Plainview, New York, United States

Family Practice of St. Cloud PA Wilker/Powers Center for Clinical Studies

🇺🇸

St. Cloud, Florida, United States

Sarasota Arthritis Center

🇺🇸

Sarasota, Florida, United States

Wilker/Powers Center for Clinical Studies

🇺🇸

St. Cloud, Florida, United States

Crest Clinical Research, Inc

🇺🇸

Anaheim, California, United States

Valerius Medical Group & Research Center Inc.

🇺🇸

Long Beach, California, United States

University Neurology

🇺🇸

Sarasota, Florida, United States

Ocala Rheumatology Research Center

🇺🇸

Ocala, Florida, United States

Orange County Clinical Research

🇺🇸

Cypress, California, United States

Medical Research Associates

🇺🇸

Clearwater, Florida, United States

Orrin M. Troum & Medical Associates

🇺🇸

Santa Monica, California, United States

America's Doctor (SMO)

🇺🇸

Gurnee, Illinois, United States

Edwards Lake Medical Center

🇺🇸

Birmingham, Alabama, United States

Scripps Clinic Ranchro Bernardo

🇺🇸

San Diego, California, United States

Mountainview Clinical Research

🇺🇸

Denver, Colorado, United States

LifeSpan Clinical Research

🇺🇸

Miami, Florida, United States

COR Clinical Research, LLC

🇺🇸

Oklahoma City, Oklahoma, United States

Arthritis Northwest

🇺🇸

Seattle, Washington, United States

LifeTree Clinical Reseach

🇺🇸

Salt Lake City, Utah, United States

J. Lewis Research Foothill Family Clinic

🇺🇸

Salt Lake City, Utah, United States

J. Lewis Research Foothill Family Clinic South

🇺🇸

Salt Lake City, Utah, United States

Andwell Research

🇺🇸

Laguna Niguel, California, United States

Clinical Investigative Services Med College of Georgia

🇺🇸

Augusta, Georgia, United States

Diablo Clinical Research

🇺🇸

Walnut Creek, California, United States

Rheumatogogy Associates of N. Alabama,

🇺🇸

Huntsville, Alabama, United States

Drug Research and Analysis Corp.

🇺🇸

Montgomery, Alabama, United States

Parkway Medical Center

🇺🇸

Birmingham, Alabama, United States

Central Arkansas Research

🇺🇸

Hot Springs, Arkansas, United States

Anesthesiology and Pain Management

🇺🇸

Los Gatos, California, United States

Pinnacle Trials, Inc.

🇺🇸

Atlanta, Georgia, United States

Dolby Providers, Inc.

🇺🇸

New Orleans, Louisiana, United States

Research Center of the Ozarks, , MO

🇺🇸

Everton, Missouri, United States

Lake Michigan Clinical Research and Consulting, Inc.

🇺🇸

St. Joseph, Michigan, United States

Professional Clinical Research

🇺🇸

Cadillac, Michigan, United States

Charlotte Spine Center Pain and Orthopedic Neurology, Pain Research Institute of the Carolinas

🇺🇸

Charlotte, North Carolina, United States

Cherry Hill Orthopedic Surgeons

🇺🇸

Cherry Hill, New Jersey, United States

Crescent Medical Assoc.

🇺🇸

Astoria, New York, United States

State University of NY at Stonybrook

🇺🇸

Stonybrook, New York, United States

Albermarle Family Practice

🇺🇸

Elizabeth City, North Carolina, United States

New Hanover Medical Research

🇺🇸

Wilmington, North Carolina, United States

Midwest Regional Research

🇺🇸

Bellbrook, Ohio, United States

Lyle, Austin Alexander PA

🇺🇸

Tulsa, Oklahoma, United States

Keystone Clinical Solutions, Inc.

🇺🇸

Altoona, Pennsylvania, United States

Rouge Valley Clinical Research

🇺🇸

Medford, Oregon, United States

Arcuri Clinical Research

🇺🇸

Philadelphia, Pennsylvania, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

Integrity Clinical Research, LLC (SMO)

🇺🇸

Milan, Tennessee, United States

Arthritis Clinic of No. Virginia

🇺🇸

Arlington, Virginia, United States

MedSource

🇺🇸

Richmond, Virginia, United States

Vantage Clinical Research Group

🇺🇸

Lacey, Washington, United States

Clinical Trials Northwest

🇺🇸

Yakima, Washington, United States

The Arthritis & Osteoporosis Center

🇺🇸

Orangeburg, South Carolina, United States

Alpha Clinical Research

🇺🇸

Clarksville, Tennessee, United States

Univeristy of Medicine and Dentistry of New Jersey

🇺🇸

Stratford, New Jersey, United States

Research Solutions, LLC

🇺🇸

Searcy, Arizona, United States

Meadowbrook Research

🇺🇸

Scottsdale, Arizona, United States

Odyssey Research Services

🇺🇸

Bismark, North Dakota, United States

© Copyright 2025. All Rights Reserved by MedPath